Aptahem Investor Relations Material
Latest events
Q1 2025
22 May, 2025
Q4 2024
14 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aptahem
Access all reports
Aptahem AB is a Sweden-based biotechnology company specializing in the development of innovative therapies for severe and acute conditions. The company focuses on drug candidates that target inflammatory and coagulation disorders, such as sepsis and other life-threatening diseases. The company is headquartered in Malmö, Sweden, and its shares are listed on the Spotlight Stock Market.
)
)
)